title: What ails the FDA?
authors.forename: Susan
authors.initials: S
authors.lastname: Okie
mesh_terms: D000288:Administrative Personnel; D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D005249:Fees and Charges / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D013450:Sulfones / Q000009:adverse effects; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000458:organization & administration*
chemical_list: D000928:Antidepressive Agents; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib